The Impact of Inflation and Wage Growth on Japan’s Economy What Goldman Sachs Predicts for Japan in the Coming Year Goldman Sachs recently released their outlook for Japan in the upcoming year, and one of the key points mentioned is their expectation for core CPI inflation to decelerate after reaching a peak of around 3.5%…
Get Ready for a Game-Changing Announcement from Federal Reserve Chair Powell! What to Expect On Wednesday, Federal Reserve Chair Powell is set to make a highly anticipated announcement that is expected to have a major impact on financial markets. Speculation is rife that Powell will deliver a hawkish policy message, hinting at a significant rate…
Pasithea Therapeutics Postpones Special Meeting Miami Beach, Fla., Nov. 28, 2022 (GLOBE NEWSWIRE) Introduction Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a biotechnology company focused on the discovery, research and development of innovative treatments for central nervous system (“CNS”) disorders, announced that it has postponed its Special Stockholder Meeting originally scheduled for November…
Big News in the Investing World! What’s the Buzz? Hey there, folks! Have you heard the latest news coming out of Wall Street? Pomerantz LLP is currently in the midst of investigating claims on behalf of investors of Lincoln National Corporation, also known as Lincoln on the NYSE. Investors are being advised to reach out…
Breaking News: Treace Medical Concepts Receives FDA Clearance for SpeedPlate™ Rapid Compression Implant Technology The Next Big Thing in Bunion Surgery PONTE VEDRA, Fla., Nov. 28, 2022 (GLOBE NEWSWIRE) — Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI) has just scored a major win in the world of medical technology. The company has…
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Vintage Wine Estates, Inc. (VWE) LOS ANGELES, Nov. 28, 2022 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming January 13, 2023 deadline to file a lead plaintiff motion in the class action filed…
The global Gastrodin market is expected to rise significantly over the next five years Double Rainbow Announces World’s First Commercial-Scale Biosynthetic Gastrodin, a Natural Marvel Lexington, Mass., Nov. 28, 2022 (GLOBE NEWSWIRE) — DoubleRainbow Biosciences (“Double Rainbow”), a sustainable biotech company harnessing bioengineering to improve the quality of human health, today announced the world’s first…
BioCryst Announces Approval of ORLADEYO® (berotralstat) by the Israeli Ministry of Health RESEARCH TRIANGLE PARK, N.C., Nov. 28, 2022 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the Israeli Ministry of Health has granted marketing authorization for oral, once-daily ORLADEYO® (berotralstat) to prevent attacks of hereditary angioedema (HAE) in adults and pediatric…
